HEADER TRANSFERASE 07-SEP-21 7VDU TITLE THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH TITLE 2 COMPOUND 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: CELL DIVISION PROTEIN KINASE 2; COMPND 6 EC: 2.7.11.22; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CDK2, CDKN2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.MALOJCIC,S.L.CLUGSTON,M.DANIELS,J.C.HARMANGE,M.LEDEBORER REVDAT 2 29-NOV-23 7VDU 1 REMARK REVDAT 1 09-MAR-22 7VDU 0 JRNL AUTH M.H.DANIELS,G.MALOJCIC,S.L.CLUGSTON,B.WILLIAMS, JRNL AUTH 2 M.COEFFET-LE GAL,X.R.PAN-ZHOU,S.VENKATACHALAN,J.C.HARMANGE, JRNL AUTH 3 M.LEDEBOER JRNL TITL DISCOVERY AND OPTIMIZATION OF HIGHLY SELECTIVE INHIBITORS OF JRNL TITL 2 CDK5. JRNL REF J.MED.CHEM. V. 65 3575 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 35143203 JRNL DOI 10.1021/ACS.JMEDCHEM.1C02069 REMARK 2 REMARK 2 RESOLUTION. 1.53 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0155 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.53 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 38061 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.180 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.800 REMARK 3 FREE R VALUE TEST SET COUNT : 4150 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.53 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.57 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2806 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.74 REMARK 3 BIN R VALUE (WORKING SET) : 0.2720 REMARK 3 BIN FREE R VALUE SET COUNT : 301 REMARK 3 BIN FREE R VALUE : 0.3230 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2339 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 230 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.96 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.02000 REMARK 3 B22 (A**2) : -0.35000 REMARK 3 B33 (A**2) : 0.37000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.120 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.091 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.066 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.145 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.969 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.956 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2474 ; 0.010 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2384 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3378 ; 1.450 ; 1.991 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5483 ; 1.700 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 305 ; 5.459 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 99 ;40.053 ;23.636 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 407 ;13.196 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;12.592 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 376 ; 0.083 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2776 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 563 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 4858 ; 3.948 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 136 ;17.305 ; 5.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 4878 ; 5.402 ; 5.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7VDU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-SEP-21. REMARK 100 THE DEPOSITION ID IS D_1300024422. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-AUG-18 REMARK 200 TEMPERATURE (KELVIN) : 100.000 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.999891638756 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42212 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.530 REMARK 200 RESOLUTION RANGE LOW (A) : 50.810 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.5700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.53 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.470 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1GZ8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% (W/V) PEG 3350, 0.10 M MES REMARK 280 PH=7.00, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.92550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.36550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.51750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 35.36550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.92550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.51750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 38 REMARK 465 THR A 39 REMARK 465 GLU A 40 REMARK 465 THR A 41 REMARK 465 GLU A 42 REMARK 465 GLY A 43 REMARK 465 VAL A 44 REMARK 465 ARG A 297 REMARK 465 LEU A 298 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 6 CE NZ REMARK 480 LEU A 25 CD1 CD2 REMARK 480 GLU A 28 CD OE1 OE2 REMARK 480 LYS A 34 NZ REMARK 480 ARG A 36 NE CZ NH1 NH2 REMARK 480 SER A 46 OG REMARK 480 ARG A 50 NE CZ NH1 NH2 REMARK 480 LYS A 75 NZ REMARK 480 LYS A 88 NZ REMARK 480 LYS A 89 CE NZ REMARK 480 LEU A 96 CD1 CD2 REMARK 480 ARG A 122 CZ NH1 NH2 REMARK 480 ARG A 150 NE CZ NH1 NH2 REMARK 480 LYS A 178 CD CE NZ REMARK 480 LYS A 273 CD CE NZ REMARK 480 HIS A 295 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 126 -6.30 79.80 REMARK 500 ASP A 127 49.01 -148.69 REMARK 500 PRO A 254 41.92 -100.81 REMARK 500 PHE A 285 -37.51 -39.50 REMARK 500 REMARK 500 REMARK: NULL DBREF 7VDU A 1 298 UNP P24941 CDK2_HUMAN 1 298 SEQADV 7VDU GLY A -1 UNP P24941 EXPRESSION TAG SEQADV 7VDU ALA A 0 UNP P24941 EXPRESSION TAG SEQRES 1 A 300 GLY ALA MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY SEQRES 2 A 300 GLU GLY THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS SEQRES 3 A 300 LEU THR GLY GLU VAL VAL ALA LEU KCX LYS ILE ARG LEU SEQRES 4 A 300 ASP THR GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG SEQRES 5 A 300 GLU ILE SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE SEQRES 6 A 300 VAL LYS LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU SEQRES 7 A 300 TYR LEU VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS SEQRES 8 A 300 PHE MET ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO SEQRES 9 A 300 LEU ILE LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU SEQRES 10 A 300 ALA PHE CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU SEQRES 11 A 300 LYS PRO GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE SEQRES 12 A 300 LYS LEU ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL SEQRES 13 A 300 PRO VAL ARG THR TYR THR HIS GLU VAL VAL THR LEU TRP SEQRES 14 A 300 TYR ARG ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SEQRES 15 A 300 SER THR ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE SEQRES 16 A 300 ALA GLU MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SEQRES 17 A 300 SER GLU ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU SEQRES 18 A 300 GLY THR PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER SEQRES 19 A 300 MET PRO ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG SEQRES 20 A 300 GLN ASP PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP SEQRES 21 A 300 GLY ARG SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO SEQRES 22 A 300 ASN LYS ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO SEQRES 23 A 300 PHE PHE GLN ASP VAL THR LYS PRO VAL PRO HIS LEU ARG SEQRES 24 A 300 LEU MODRES 7VDU KCX A 33 LYS MODIFIED RESIDUE HET KCX A 33 12 HET 65L A 301 37 HETNAM KCX LYSINE NZ-CARBOXYLIC ACID HETNAM 65L [1-[3-FLUORANYL-4-[(2-PIPERIDIN-4-YLOXY-1,6- HETNAM 2 65L NAPHTHYRIDIN-7-YL)AMINO]PHENYL]PYRAZOL-3-YL]METHANOL FORMUL 1 KCX C7 H14 N2 O4 FORMUL 2 65L C23 H23 F N6 O2 FORMUL 3 HOH *230(H2 O) HELIX 1 AA1 GLY A -1 GLU A 2 5 4 HELIX 2 AA2 SER A 46 LEU A 55 1 10 HELIX 3 AA3 LYS A 56 LEU A 58 5 3 HELIX 4 AA4 LEU A 87 SER A 94 1 8 HELIX 5 AA5 PRO A 100 HIS A 121 1 22 HELIX 6 AA6 LYS A 129 GLN A 131 5 3 HELIX 7 AA7 GLY A 147 GLY A 153 1 7 HELIX 8 AA8 ALA A 170 LEU A 175 1 6 HELIX 9 AA9 THR A 182 ARG A 199 1 18 HELIX 10 AB1 SER A 207 GLY A 220 1 14 HELIX 11 AB2 GLY A 229 MET A 233 5 5 HELIX 12 AB3 ASP A 247 VAL A 252 1 6 HELIX 13 AB4 ASP A 256 LEU A 267 1 12 HELIX 14 AB5 SER A 276 ALA A 282 1 7 HELIX 15 AB6 HIS A 283 GLN A 287 5 5 SHEET 1 AA1 5 PHE A 4 GLU A 12 0 SHEET 2 AA1 5 GLY A 16 ASN A 23 -1 O LYS A 20 N GLU A 8 SHEET 3 AA1 5 VAL A 29 ARG A 36 -1 O LEU A 32 N TYR A 19 SHEET 4 AA1 5 LYS A 75 GLU A 81 -1 O PHE A 80 N ALA A 31 SHEET 5 AA1 5 LEU A 66 THR A 72 -1 N ILE A 70 O TYR A 77 SHEET 1 AA2 3 GLN A 85 ASP A 86 0 SHEET 2 AA2 3 LEU A 133 ILE A 135 -1 O ILE A 135 N GLN A 85 SHEET 3 AA2 3 ILE A 141 LEU A 143 -1 O LYS A 142 N LEU A 134 LINK C LEU A 32 N KCX A 33 1555 1555 1.34 LINK C KCX A 33 N LYS A 34 1555 1555 1.33 CISPEP 1 PRO A 253 PRO A 254 0 2.86 CRYST1 53.851 73.035 70.731 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018570 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013692 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014138 0.00000